Aveanna Healthcare (NASDAQ:AVAH) Price Target Cut to $8.00 by Analysts at Truist Financial

Aveanna Healthcare (NASDAQ:AVAH) had its target price cut by Truist Financial from $9.00 to $8.00 in a report published on Monday morning,Benzinga reports. They currently have a hold rating on the stock.

Several other research firms have also commented on AVAH. UBS Group boosted their price target on Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday, January 15th. Raymond James Financial raised Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target for the company in a research report on Friday, March 20th. Weiss Ratings lowered Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. BMO Capital Markets reduced their price target on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 20th. Finally, Royal Bank Of Canada reduced their target price on Aveanna Healthcare from $11.00 to $9.00 and set a “sector perform” rating on the stock in a research report on Monday, March 23rd. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, Aveanna Healthcare currently has an average rating of “Moderate Buy” and an average target price of $10.25.

Aveanna Healthcare Trading Up 3.4%

AVAH opened at $6.43 on Monday. The firm has a market cap of $1.40 billion, a price-to-earnings ratio of 6.30 and a beta of 2.08. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 6.62. Aveanna Healthcare has a 12 month low of $3.73 and a 12 month high of $10.32. The stock has a fifty day moving average price of $7.09 and a 200-day moving average price of $8.29.

Insiders Place Their Bets

In related news, insider Patrick A. Cunningham sold 18,436 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $132,923.56. Following the transaction, the insider directly owned 337,755 shares of the company’s stock, valued at $2,435,213.55. This represents a 5.18% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Jeff Shaner sold 173,225 shares of the business’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $1,248,952.25. Following the sale, the chief executive officer owned 2,650,892 shares in the company, valued at approximately $19,112,931.32. The trade was a 6.13% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 738,957 shares of company stock valued at $5,458,175. 7.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Aveanna Healthcare

Several large investors have recently added to or reduced their stakes in the company. AustralianSuper Pty Ltd purchased a new stake in shares of Aveanna Healthcare in the third quarter worth about $15,743,000. Vanguard Group Inc. boosted its stake in shares of Aveanna Healthcare by 38.0% in the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after buying an additional 1,535,351 shares during the last quarter. Millennium Management LLC boosted its stake in shares of Aveanna Healthcare by 1,007.1% in the fourth quarter. Millennium Management LLC now owns 1,114,717 shares of the company’s stock worth $9,107,000 after buying an additional 1,014,030 shares during the last quarter. Nuveen LLC boosted its stake in shares of Aveanna Healthcare by 135.9% in the fourth quarter. Nuveen LLC now owns 1,571,308 shares of the company’s stock worth $12,838,000 after buying an additional 905,316 shares during the last quarter. Finally, Hillsdale Investment Management Inc. purchased a new stake in shares of Aveanna Healthcare in the third quarter worth about $7,922,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.